{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:50:49Z","timestamp":1790657449053,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"crossref","award":["COST Action BM1404 Mye-EUNITER (www.mye-euniter.eu)"],"award-info":[{"award-number":["COST Action BM1404 Mye-EUNITER (www.mye-euniter.eu)"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00262-018-2277-y","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:57:11Z","timestamp":1545181031000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["MDSCs in infectious diseases: regulation, roles, and readjustment"],"prefix":"10.1007","volume":"68","author":[{"given":"Anca","family":"Dorhoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-9629","authenticated-orcid":false,"given":"Estibaliz","family":"Glar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-3134","authenticated-orcid":false,"given":"Thalia","family":"Garcia-Tellez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-2462","authenticated-orcid":false,"given":"Natalie E.","family":"Nieuwenhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-2382","authenticated-orcid":false,"given":"Gennadiy","family":"Zelinskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9191-6273","authenticated-orcid":false,"given":"Benoit","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-1038","authenticated-orcid":false,"given":"Anurag","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ehrchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Gujer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-1940","authenticated-orcid":false,"given":"Christian","family":"M\u00fcnz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-1293","authenticated-orcid":false,"given":"Margarida","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5268-238X","authenticated-orcid":false,"given":"Yahya","family":"Sohrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-9799","authenticated-orcid":false,"given":"Ana E.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3972-616X","authenticated-orcid":false,"given":"Peter","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3854-2396","authenticated-orcid":false,"given":"Michaela","family":"M\u00fcller-Trutwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-2633","authenticated-orcid":false,"given":"Annabel F.","family":"Valledor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"2277_CR1","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen S-H et al (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7:12150. \n                    https:\/\/doi.org\/10.1038\/ncomms12150","journal-title":"Nat Commun"},{"key":"2277_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2170-8","author":"AM Bruger","year":"2018","unstructured":"Bruger AM, Dorhoi A, Esendagli G et al (2018) How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Cancer Immunol Immunother. \n                    https:\/\/doi.org\/10.1007\/s00262-018-2170-8","journal-title":"Cancer Immunol Immunother"},{"key":"2277_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.immuni.2014.10.009","volume":"41","author":"Y Skabytska","year":"2014","unstructured":"Skabytska Y, W\u00f6lbing F, G\u00fcnther C et al (2014) Cutaneous innate immune sensing of toll-like receptor 2\u20136 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 41:762\u2013775. \n                    https:\/\/doi.org\/10.1016\/J.IMMUNI.2014.10.009","journal-title":"Immunity"},{"key":"2277_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/mi.2010.41","volume":"3","author":"M Arora","year":"2010","unstructured":"Arora M, Poe SL, Oriss TB et al (2010) TLR4\/MyD88-induced CD11b+ Gr-1 int F4\/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol 3:578\u2013593. \n                    https:\/\/doi.org\/10.1038\/mi.2010.41","journal-title":"Mucosal Immunol"},{"key":"2277_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4049\/jimmunol.1202144","volume":"190","author":"N Rieber","year":"2013","unstructured":"Rieber N, Brand A, Hector A et al (2013) Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 190:1276\u20131284. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1202144","journal-title":"J Immunol"},{"key":"2277_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/imm.12616","volume":"148","author":"JP Ren","year":"2016","unstructured":"Ren JP, Zhao J, Dai J et al (2016) Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway. Immunology 148:377\u2013386. \n                    https:\/\/doi.org\/10.1111\/imm.12616","journal-title":"Immunology"},{"key":"2277_CR7","doi-asserted-by":"publisher","first-page":"e0170516","DOI":"10.1371\/journal.pone.0170516","volume":"12","author":"N Zhai","year":"2017","unstructured":"Zhai N, Li H, Song H et al (2017) Hepatitis C virus induces MDSCs-like monocytes through TLR2\/PI3K\/AKT\/STAT3 signaling. PLoS One 12:e0170516. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0170516","journal-title":"PLoS One"},{"key":"2277_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.24700","volume":"55","author":"RS Tacke","year":"2012","unstructured":"Tacke RS, Lee H-C, Goh C et al (2012) Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55:343\u2013353. \n                    https:\/\/doi.org\/10.1002\/hep.24700","journal-title":"Hepatology"},{"key":"2277_CR9","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.4049\/jimmunol.1501881","volume":"196","author":"CC Goh","year":"2016","unstructured":"Goh CC, Roggerson KM, Lee H-C et al (2016) Hepatitis C virus-induced myeloid-derived suppressor cells suppress NK cell IFN-\u03b3 production by altering cellular metabolism via arginase-1. J Immunol 196:2283\u20132292. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1501881","journal-title":"J Immunol"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.4049\/jimmunol.1501362","volume":"195","author":"Z Fang","year":"2015","unstructured":"Fang Z, Li J, Yu X et al (2015) Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK\/IL-6\/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection. J Immunol 195:4873\u20134883. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1501362","journal-title":"J Immunol"},{"key":"2277_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/infdis\/jit469","volume":"209","author":"A Garg","year":"2014","unstructured":"Garg A, Spector SA (2014) HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J Infect Dis 209:441\u2013451. \n                    https:\/\/doi.org\/10.1093\/infdis\/jit469","journal-title":"J Infect Dis"},{"key":"2277_CR12","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3389\/fimmu.2017.01895","volume":"8","author":"A Dorhoi","year":"2018","unstructured":"Dorhoi A, Du Plessis N (2018) Monocytic myeloid-derived suppressor cells in chronic infections. Front Immunol 8:1895. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.01895","journal-title":"Front Immunol"},{"key":"2277_CR13","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1172\/JCI36264","volume":"118","author":"C Santo De","year":"2008","unstructured":"De Santo C, Salio M, Masri SH et al (2008) Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 118:4036\u20134048. \n                    https:\/\/doi.org\/10.1172\/JCI36264","journal-title":"J Clin Invest"},{"key":"2277_CR14","doi-asserted-by":"publisher","first-page":"e25242","DOI":"10.1371\/journal.pone.0025242","volume":"6","author":"V Jeisy-Scott","year":"2011","unstructured":"Jeisy-Scott V, Davis WG, Patel JR et al (2011) Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice. PLoS One 6:e25242. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0025242","journal-title":"PLoS One"},{"key":"2277_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.chom.2015.02.007","volume":"17","author":"N Rieber","year":"2015","unstructured":"Rieber N, Singh A, \u00d6z H et al (2015) Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells. Cell Host Microbe 17:507\u2013514. \n                    https:\/\/doi.org\/10.1016\/j.chom.2015.02.007","journal-title":"Cell Host Microbe"},{"key":"2277_CR16","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.4049\/jimmunol.1501853","volume":"196","author":"SH Albeituni","year":"2016","unstructured":"Albeituni SH, Ding C, Liu M et al (2016) Yeast-derived particulate \u03b2-glucan treatment subverts the suppression of myeloid-derived suppressor cells (MDSC) by inducing polymorphonuclear MDSC apoptosis and monocytic MDSC differentiation to APC in cancer. J Immunol 196:2167\u20132180. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1501853","journal-title":"J Immunol"},{"key":"2277_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-3024.2005.00790.x","volume":"27","author":"L Gomez-Garcia","year":"2005","unstructured":"Gomez-Garcia L, Lopez-Marin LM, Saavedra R et al (2005) Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells. Parasite Immunol 27:395\u2013405. \n                    https:\/\/doi.org\/10.1111\/j.1365-3024.2005.00790.x","journal-title":"Parasite Immunol"},{"key":"2277_CR18","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.4049\/jimmunol.167.9.5294","volume":"167","author":"LI Terrazas","year":"2001","unstructured":"Terrazas LI, Walsh KL, Piskorska D et al (2001) The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections. J Immunol 167:5294\u20135303","journal-title":"J Immunol"},{"key":"2277_CR19","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.4049\/jimmunol.167.8.4293","volume":"167","author":"O Atochina","year":"2001","unstructured":"Atochina O, Daly-Engel T, Piskorska D et al (2001) A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism. J Immunol 167:4293\u20134302","journal-title":"J Immunol"},{"key":"2277_CR20","doi-asserted-by":"publisher","first-page":"e0155081","DOI":"10.1371\/journal.pone.0155081","volume":"11","author":"A Wagner","year":"2016","unstructured":"Wagner A, Schabussova I, Drinic M et al (2016) Oocyst-derived extract of Toxoplasma gondii serves as potent immunomodulator in a mouse model of birch pollen allergy. PLoS One 11:e0155081. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0155081","journal-title":"PLoS One"},{"key":"2277_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fcimb.2016.00037","volume":"6","author":"M Ost","year":"2016","unstructured":"Ost M, Singh A, Peschel A et al (2016) Myeloid-derived suppressor cells in bacterial infections. Front Cell Infect Microbiol 6:37. \n                    https:\/\/doi.org\/10.3389\/fcimb.2016.00037","journal-title":"Front Cell Infect Microbiol"},{"key":"2277_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174. \n                    https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"key":"2277_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D (2018) Myeloid-derived suppressor cells coming of age. Nat Immunol 19:108\u2013119. \n                    https:\/\/doi.org\/10.1038\/s41590-017-0022-x","journal-title":"Nat Immunol"},{"key":"2277_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/eji.201343606","volume":"44","author":"AR Arocena","year":"2014","unstructured":"Arocena AR, Onofrio LI, Pellegrini AV et al (2014) Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. Eur J Immunol 44:184\u2013194. \n                    https:\/\/doi.org\/10.1002\/eji.201343606","journal-title":"Eur J Immunol"},{"key":"2277_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1084\/jem.20091474","volume":"207","author":"LE Sander","year":"2010","unstructured":"Sander LE, Sackett SD, Dierssen U et al (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 207:1453\u20131464. \n                    https:\/\/doi.org\/10.1084\/jem.20091474","journal-title":"J Exp Med"},{"key":"2277_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1182\/bloodadvances.2017006858","volume":"1","author":"E Ribechini","year":"2017","unstructured":"Ribechini E, Hutchinson JA, Hergovits S et al (2017) Novel GM-CSF signals via IFN-\u03b3R\/IRF-1 and AKT\/mTOR license monocytes for suppressor function. Blood Adv 1:947\u2013960. \n                    https:\/\/doi.org\/10.1182\/bloodadvances.2017006858","journal-title":"Blood Adv"},{"key":"2277_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2014.10.020","volume":"41","author":"JM Haverkamp","year":"2014","unstructured":"Haverkamp JM, Smith AM, Weinlich R et al (2014) Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. Immunity 41:947\u2013959. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2014.10.020","journal-title":"Immunity"},{"key":"2277_CR28","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.4049\/jimmunol.1700671","volume":"199","author":"C Wang","year":"2017","unstructured":"Wang C, Zhang N, Qi L et al (2017) Myeloid-derived suppressor cells inhibit T follicular helper cell immune response in japanese encephalitis virus infection. J Immunol 199:3094\u20133105. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1700671","journal-title":"J Immunol"},{"key":"2277_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12977-017-0364-3","volume":"14","author":"M Drabczyk-Pluta","year":"2017","unstructured":"Drabczyk-Pluta M, Werner T, Hoffmann D et al (2017) Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8+ T cell responses during acute friend retrovirus infection. Retrovirology 14:42. \n                    https:\/\/doi.org\/10.1186\/s12977-017-0364-3","journal-title":"Retrovirology"},{"key":"2277_CR30","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1128\/IAI.72.9.5487-5492.2004","volume":"72","author":"M-B Voisin","year":"2004","unstructured":"Voisin M-B, Buzoni-Gatel D, Bout D, Velge-Roussel F (2004) Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect Immun 72:5487\u20135492. \n                    https:\/\/doi.org\/10.1128\/IAI.72.9.5487-5492.2004","journal-title":"Infect Immun"},{"key":"2277_CR31","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1186\/cc14003","volume":"18","author":"CJ Darcy","year":"2014","unstructured":"Darcy CJ, Minigo G, Piera KA et al (2014) Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care 18:R163. \n                    https:\/\/doi.org\/10.1186\/cc14003","journal-title":"Crit Care"},{"key":"2277_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1189\/jlb.5HI0214-074R","volume":"96","author":"H Janols","year":"2014","unstructured":"Janols H, Bergenfelz C, Allaoui R et al (2014) A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases. J Leukoc Biol 96:685\u2013693. \n                    https:\/\/doi.org\/10.1189\/jlb.5HI0214-074R","journal-title":"J Leukoc Biol"},{"key":"2277_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","volume":"196","author":"F Uhel","year":"2017","unstructured":"Uhel F, Azzaoui I, Gr\u00e9goire M et al (2017) Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis. Am J Respir Crit Care Med 196:315\u2013327. \n                    https:\/\/doi.org\/10.1164\/rccm.201606-1143OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2277_CR34","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1084\/jem.20062602","volume":"204","author":"MJ Delano","year":"2007","unstructured":"Delano MJ, Scumpia PO, Weinstein JS et al (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 204:1463\u20131474. \n                    https:\/\/doi.org\/10.1084\/jem.20062602","journal-title":"J Exp Med"},{"key":"2277_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/mi.2012.62","volume":"6","author":"SL Poe","year":"2013","unstructured":"Poe SL, Arora M, Oriss TB et al (2013) STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol 6:189\u2013199. \n                    https:\/\/doi.org\/10.1038\/mi.2012.62","journal-title":"Mucosal Immunol"},{"key":"2277_CR36","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.4049\/jimmunol.1002928","volume":"187","author":"H Cuervo","year":"2011","unstructured":"Cuervo H, Guerrero NA, Carbajosa S et al (2011) Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol 187:2656\u20132665. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1002928","journal-title":"J Immunol"},{"key":"2277_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fimmu.2016.00626","volume":"7","author":"LM Sanmarco","year":"2016","unstructured":"Sanmarco LM, Visconti LM, Eberhardt N et al (2016) IL-6 improves the nitric oxide-induced cytotoxic CD8+ T cell dysfunction in human chagas disease. Front Immunol 7:626. \n                    https:\/\/doi.org\/10.3389\/fimmu.2016.00626","journal-title":"Front Immunol"},{"key":"2277_CR38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A (2010) Nonresolving Inflammation. Cell 140:871\u2013882. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.02.029","journal-title":"Cell"},{"key":"2277_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/CMR.00124-13","volume":"27","author":"MK White","year":"2014","unstructured":"White MK, Pagano JS, Khalili K (2014) Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev 27:463\u2013481. \n                    https:\/\/doi.org\/10.1128\/CMR.00124-13","journal-title":"Clin Microbiol Rev"},{"key":"2277_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1128\/CMR.00012-10","volume":"23","author":"AH Chang","year":"2010","unstructured":"Chang AH, Parsonnet J (2010) Role of bacteria in oncogenesis. Clin Microbiol Rev 23:837\u2013857. \n                    https:\/\/doi.org\/10.1128\/CMR.00012-10","journal-title":"Clin Microbiol Rev"},{"key":"2277_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ebiom.2016.11.034","volume":"15","author":"H Tong van","year":"2017","unstructured":"van Tong H, Brindley PJ, Meyer CG, Velavan TP (2017) Parasite infection, carcinogenesis and human malignancy. EBioMedicine 15:12\u201323. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2016.11.034","journal-title":"EBioMedicine"},{"key":"2277_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.imlet.2013.12.003","volume":"158","author":"B Yang","year":"2014","unstructured":"Yang B, Wang X, Jiang J et al (2014) Identification of CD244-expressing myeloid-derived suppressor cells in patients with active tuberculosis. Immunol Lett 158:66\u201372. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2013.12.003","journal-title":"Immunol Lett"},{"key":"2277_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","volume":"188","author":"N Plessis du","year":"2013","unstructured":"du Plessis N, Loebenberg L, Kriel M et al (2013) Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent Mycobacterium tuberculosis infection suppresses T-cell function. Am J Respir Crit Care Med 188:724\u2013732. \n                    https:\/\/doi.org\/10.1164\/rccm.201302-0249OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2277_CR44","doi-asserted-by":"publisher","first-page":"e0123772","DOI":"10.1371\/journal.pone.0123772","volume":"10","author":"S Daker El","year":"2015","unstructured":"El Daker S, Sacchi A, Tempestilli M et al (2015) Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level. PLoS One 10:e0123772. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0123772","journal-title":"PLoS One"},{"key":"2277_CR45","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","volume":"190","author":"JK Knaul","year":"2014","unstructured":"Knaul JK, J\u00f6rg S, Oberbeck-Mueller D et al (2014) Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am J Respir Crit Care Med 190:1053\u20131066. \n                    https:\/\/doi.org\/10.1164\/rccm.201405-0828OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2277_CR46","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.4049\/jimmunol.1301365","volume":"192","author":"EN Tsiganov","year":"2014","unstructured":"Tsiganov EN, Verbina EM, Radaeva TV et al (2014) Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice. J Immunol 192:4718\u20134727. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1301365","journal-title":"J Immunol"},{"key":"2277_CR47","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/infdis\/jix208","volume":"215","author":"S Gupta","year":"2017","unstructured":"Gupta S, Cheung L, Pokkali S et al (2017) Suppressor cell-depleting immunotherapy with denileukin diftitox is an effective host-directed therapy for tuberculosis. J Infect Dis 215:1883\u20131887. \n                    https:\/\/doi.org\/10.1093\/infdis\/jix208","journal-title":"J Infect Dis"},{"key":"2277_CR48","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.4049\/jimmunol.1303408","volume":"192","author":"CE Heim","year":"2014","unstructured":"Heim CE, Vidlak D, Scherr TD et al (2014) Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection. J Immunol 192:3778\u20133792. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1303408","journal-title":"J Immunol"},{"key":"2277_CR49","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1172\/JCI82529","volume":"126","author":"L Ding","year":"2016","unstructured":"Ding L, Hayes MM, Photenhauer A et al (2016) Schlafen 4\u2013expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia. J Clin Invest 126:2867\u20132880. \n                    https:\/\/doi.org\/10.1172\/JCI82529","journal-title":"J Clin Invest"},{"key":"2277_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/mi.2016.53","volume":"10","author":"E Thiele Orberg","year":"2017","unstructured":"Thiele Orberg E, Fan H, Tam AJ et al (2017) The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol 10:421\u2013433. \n                    https:\/\/doi.org\/10.1038\/mi.2016.53","journal-title":"Mucosal Immunol"},{"key":"2277_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.immuni.2012.10.022","volume":"38","author":"BA Norris","year":"2013","unstructured":"Norris BA, Uebelhoer LS, Nakaya HI et al (2013) Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38:309\u2013321. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2012.10.022","journal-title":"Immunity"},{"key":"2277_CR52","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1128\/JVI.01547-12","volume":"87","author":"KA Green","year":"2013","unstructured":"Green KA, Cook WJ, Green WR (2013) Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency. J Virol 87:2058\u20132071. \n                    https:\/\/doi.org\/10.1128\/JVI.01547-12","journal-title":"J Virol"},{"key":"2277_CR53","doi-asserted-by":"publisher","unstructured":"Alaoui L, Palomino G, Zurawski S et al (2017) Early SIV and HIV infection promotes the LILRB2\/MHC-I inhibitory axis in cDCs. Cell Mol Life Sci 1\u201317. \n                    https:\/\/doi.org\/10.1007\/s00018-017-2712-9","DOI":"10.1007\/s00018-017-2712-9"},{"key":"2277_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.coviro.2016.06.011","volume":"19","author":"N Huot","year":"2016","unstructured":"Huot N, Rascle P, Garcia-Tellez T et al (2016) Innate immune cell responses in non pathogenic versus pathogenic SIV infections. Curr Opin Virol 19:37\u201344. \n                    https:\/\/doi.org\/10.1016\/j.coviro.2016.06.011","journal-title":"Curr Opin Virol"},{"key":"2277_CR55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/QAI.0000000000001471","volume":"76","author":"Z-N Zhang","year":"2017","unstructured":"Zhang Z-N, Yi N, Zhang T-W et al (2017) Myeloid-derived suppressor cells associated with disease progression in primary HIV infection. JAIDS J Acquir Immune Defic Syndr 76:200\u2013208. \n                    https:\/\/doi.org\/10.1097\/QAI.0000000000001471","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"2277_CR56","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1097\/QAD.0b013e328354b43f","volume":"26","author":"T Vollbrecht","year":"2012","unstructured":"Vollbrecht T, Stirner R, Tufman A et al (2012) Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26:F31\u2013F37. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e328354b43f","journal-title":"AIDS"},{"key":"2277_CR57","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1097\/QAD.0000000000000871","volume":"29","author":"N Tumino","year":"2015","unstructured":"Tumino N, Turchi F, Meschi S et al (2015) In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3 \u03b6 expression through ELF-1 inhibition. AIDS 29:2397\u20132407. \n                    https:\/\/doi.org\/10.1097\/QAD.0000000000000871","journal-title":"AIDS"},{"key":"2277_CR58","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1128\/JVI.01759-12","volume":"87","author":"A Qin","year":"2013","unstructured":"Qin A, Cai W, Pan T et al (2013) Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J Virol 87:1477\u20131490. \n                    https:\/\/doi.org\/10.1128\/JVI.01759-12","journal-title":"J Virol"},{"key":"2277_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1189\/jlb.1111579","volume":"91","author":"L Gama","year":"2012","unstructured":"Gama L, Shirk EN, Russell JN et al (2012) Expansion of a subset of CD14highCD16negCCR2low\/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. J Leukoc Biol 91:803\u2013816. \n                    https:\/\/doi.org\/10.1189\/jlb.1111579","journal-title":"J Leukoc Biol"},{"key":"2277_CR60","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4049\/jimmunol.1600759","volume":"198","author":"SE Dross","year":"2017","unstructured":"Dross SE, Munson PV, Kim SE et al (2017) Kinetics of myeloid-derived suppressor cell frequency and function during simian immunodeficiency virus infection, combination antiretroviral therapy, and treatment interruption. J Immunol 198:757\u2013766. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1600759","journal-title":"J Immunol"},{"key":"2277_CR61","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10875-012-9861-2","volume":"33","author":"W Cai","year":"2013","unstructured":"Cai W, Qin A, Guo P et al (2013) Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J Clin Immunol 33:798\u2013808. \n                    https:\/\/doi.org\/10.1007\/s10875-012-9861-2","journal-title":"J Clin Immunol"},{"key":"2277_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.14348\/molcells.2014.2282","volume":"37","author":"Q-L Zeng","year":"2014","unstructured":"Zeng Q-L, Yang B, Sun H-Q et al (2014) Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR \u03b6 chain expression on CD8(+) T cells in chronic hepatitis C patients. Mol Cells 37:66\u201373. \n                    https:\/\/doi.org\/10.14348\/molcells.2014.2282","journal-title":"Mol Cells"},{"key":"2277_CR63","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1128\/JVI.00113-14","volume":"88","author":"J Nonnenmann","year":"2014","unstructured":"Nonnenmann J, Stirner R, Roider J et al (2014) Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals. J Virol 88:7678\u20137682. \n                    https:\/\/doi.org\/10.1128\/JVI.00113-14","journal-title":"J Virol"},{"key":"2277_CR64","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","volume":"193","author":"A Huang","year":"2014","unstructured":"Huang A, Zhang B, Yan W et al (2014) Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. J Immunol 193:5461\u20135469. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1400849","journal-title":"J Immunol"},{"key":"2277_CR65","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2249.2011.04445.x","volume":"166","author":"S Chen","year":"2011","unstructured":"Chen S, Akbar SMF, Abe M et al (2011) Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 166:134\u2013142. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04445.x","journal-title":"Clin Exp Immunol"},{"key":"2277_CR66","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4049\/jimmunol.1303432","volume":"193","author":"X Kong","year":"2014","unstructured":"Kong X, Sun R, Chen Y et al (2014) \u03b3\u03b4T cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol 193:1645\u20131653. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1303432","journal-title":"J Immunol"},{"key":"2277_CR67","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nm.3856","volume":"21","author":"LJ Pallett","year":"2015","unstructured":"Pallett LJ, Gill US, Quaglia A et al (2015) Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med 21:591\u2013600. \n                    https:\/\/doi.org\/10.1038\/nm.3856","journal-title":"Nat Med"},{"key":"2277_CR68","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","volume":"9","author":"E Cesarman","year":"2014","unstructured":"Cesarman E (2014) Gammaherpesviruses and lymphoproliferative disorders. Annu Rev Pathol Mech Dis 9:349\u2013372. \n                    https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104656","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2277_CR69","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bjh.13198","volume":"168","author":"A Romano","year":"2015","unstructured":"Romano A, Parrinello NL, Vetro C et al (2015) Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy. Br J Haematol 168:689\u2013700. \n                    https:\/\/doi.org\/10.1111\/bjh.13198","journal-title":"Br J Haematol"},{"key":"2277_CR70","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00262-015-1765-6","volume":"64","author":"H Zhang","year":"2015","unstructured":"Zhang H, Li Z-L, Ye S-B et al (2015) Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK\/T cell lymphoma: a novel prognostic indicator. Cancer Immunol Immunother 64:1587\u20131599. \n                    https:\/\/doi.org\/10.1007\/s00262-015-1765-6","journal-title":"Cancer Immunol Immunother"},{"key":"2277_CR71","doi-asserted-by":"publisher","first-page":"e1006503","DOI":"10.1371\/journal.ppat.1006503","volume":"13","author":"T-T Cai","year":"2017","unstructured":"Cai T-T, Ye S-B, Liu Y-N et al (2017) LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. PLOS Pathog 13:e1006503. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1006503","journal-title":"PLOS Pathog"},{"key":"2277_CR72","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jaci.2016.07.007","volume":"138","author":"RM Maizels","year":"2016","unstructured":"Maizels RM, McSorley HJ (2016) Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol 138:666\u2013675. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.07.007","journal-title":"J Allergy Clin Immunol"},{"key":"2277_CR73","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.4049\/jimmunol.1601860","volume":"198","author":"Q Yang","year":"2017","unstructured":"Yang Q, Qiu H, Xie H et al (2017) A Schistosoma japonicum infection promotes the expansion of myeloid-derived suppressor cells by activating the JAK\/STAT3 pathway. J Immunol 198:4716\u20134727. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1601860","journal-title":"J Immunol"},{"key":"2277_CR74","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/mi.2016.36","volume":"10","author":"RM Valanparambil","year":"2017","unstructured":"Valanparambil RM, Tam M, Jardim A et al (2017) Primary Heligmosomoides polygyrus bakeri infection induces myeloid-derived suppressor cells that suppress CD4+ Th2 responses and promote chronic infection. Mucosal Immunol 10:238\u2013249. \n                    https:\/\/doi.org\/10.1038\/mi.2016.36","journal-title":"Mucosal Immunol"},{"key":"2277_CR75","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1002\/eji.201040911","volume":"40","author":"JA Ginderachter Van","year":"2010","unstructured":"Van Ginderachter JA, Beschin A, De Baetselier P, Raes G (2010) Myeloid-derived suppressor cells in parasitic infections. Eur J Immunol 40:2976\u20132985. \n                    https:\/\/doi.org\/10.1002\/eji.201040911","journal-title":"Eur J Immunol"},{"key":"2277_CR76","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.4049\/jimmunol.174.10.6095","volume":"174","author":"L Brys","year":"2005","unstructured":"Brys L, Beschin A, Raes G et al (2005) Reactive oxygen species and 12\/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J Immunol 174:6095\u20136104. \n                    https:\/\/doi.org\/10.4049\/jimmunol.174.10.6095","journal-title":"J Immunol"},{"key":"2277_CR77","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1189\/jlb.1110608","volume":"90","author":"WF Pereira","year":"2011","unstructured":"Pereira WF, Ribeiro-Gomes FL, Guillermo LVC et al (2011) Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses. J Leukoc Biol 90:1191\u20131197. \n                    https:\/\/doi.org\/10.1189\/jlb.1110608","journal-title":"J Leukoc Biol"},{"key":"2277_CR78","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1002\/eji.201344335","volume":"44","author":"M Schmid","year":"2014","unstructured":"Schmid M, Zimara N, Wege AK, Ritter U (2014) Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL\/6 and BALB\/c mice. Eur J Immunol 44:3295\u20133306. \n                    https:\/\/doi.org\/10.1002\/eji.201344335","journal-title":"Eur J Immunol"},{"key":"2277_CR79","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3389\/fmicb.2016.01624","volume":"7","author":"A Singh","year":"2016","unstructured":"Singh A, Lelis F, Braig S et al (2016) Differential regulation of myeloid-derived suppressor cells by Candida species. Front Microbiol 7:1624. \n                    https:\/\/doi.org\/10.3389\/fmicb.2016.01624","journal-title":"Front Microbiol"},{"key":"2277_CR80","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1128\/IAI.00668-12","volume":"80","author":"C Zhang","year":"2012","unstructured":"Zhang C, Lei G-S, Shao S et al (2012) Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infect Immun 80:3634\u20133641. \n                    https:\/\/doi.org\/10.1128\/IAI.00668-12","journal-title":"Infect Immun"},{"key":"2277_CR81","doi-asserted-by":"publisher","first-page":"e53479","DOI":"10.1371\/journal.pone.0053479","volume":"8","author":"G-S Lei","year":"2013","unstructured":"Lei G-S, Zhang C, Shao S et al (2013) All-trans retinoic acid in combination with primaquine clears pneumocystis infection. PLoS One 8:e53479. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0053479","journal-title":"PLoS One"},{"key":"2277_CR82","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1128\/IAI.02686-14","volume":"83","author":"G-S Lei","year":"2015","unstructured":"Lei G-S, Zhang C, Lee C-H (2015) Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia. Infect Immun 83:572\u2013582. \n                    https:\/\/doi.org\/10.1128\/IAI.02686-14","journal-title":"Infect Immun"},{"key":"2277_CR83","doi-asserted-by":"publisher","first-page":"e1006395","DOI":"10.1371\/journal.ppat.1006395","volume":"13","author":"Y Sui","year":"2017","unstructured":"Sui Y, Frey B, Wang Y et al (2017) Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques. PLoS Pathog 13:e1006395. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1006395","journal-title":"PLoS Pathog"},{"key":"2277_CR84","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1128\/IAI.00057-06","volume":"74","author":"C Keller","year":"2006","unstructured":"Keller C, Hoffmann R, Lang R et al (2006) Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 74:4295\u20134309. \n                    https:\/\/doi.org\/10.1128\/IAI.00057-06","journal-title":"Infect Immun"},{"key":"2277_CR85","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1128\/IAI.73.3.1744-1753.2005","volume":"73","author":"EB Eruslanov","year":"2005","unstructured":"Eruslanov EB, Lyadova IV, Kondratieva TK et al (2005) Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 73:1744\u20131753. \n                    https:\/\/doi.org\/10.1128\/IAI.73.3.1744-1753.2005","journal-title":"Infect Immun"},{"key":"2277_CR86","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4049\/jimmunol.1400196","volume":"194","author":"C Tebartz","year":"2015","unstructured":"Tebartz C, Horst SA, Sparwasser T et al (2015) A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J Immunol 194:1100\u20131111. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1400196","journal-title":"J Immunol"},{"key":"2277_CR87","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1165\/rcmb.2016-0185OC","volume":"56","author":"BC Mourik","year":"2017","unstructured":"Mourik BC, Leenen PJM, de Knegt GJ et al (2017) Immunotherapy added to antibiotic treatment reduces relapse of disease in a mouse model of tuberculosis. Am J Respir Cell Mol Biol 56:233\u2013241. \n                    https:\/\/doi.org\/10.1165\/rcmb.2016-0185OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2277_CR88","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1158\/2326-6066.CIR-13-0123","volume":"2","author":"D Chandra","year":"2014","unstructured":"Chandra D, Quispe-Tintaya W, Jahangir A et al (2014) STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer. Cancer Immunol Res 2:901\u2013910. \n                    https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0123","journal-title":"Cancer Immunol Res"},{"key":"2277_CR89","doi-asserted-by":"publisher","first-page":"83907","DOI":"10.18632\/oncotarget.13438","volume":"7","author":"F Liu","year":"2016","unstructured":"Liu F, Li X, Lu C et al (2016) Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells. Oncotarget 7:83907\u201383925. \n                    https:\/\/doi.org\/10.18632\/oncotarget.13438","journal-title":"Oncotarget"},{"key":"2277_CR90","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2017.12.026","volume":"172","author":"MF Tavazoie","year":"2018","unstructured":"Tavazoie MF, Pollack I, Tanqueco R et al (2018) LXR\/ApoE activation restricts innate immune suppression in cancer. Cell 172:825\u2013840.e18. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.12.026","journal-title":"Cell"},{"key":"2277_CR91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ebiom.2016.02.016","volume":"4","author":"BA Ahidjo","year":"2016","unstructured":"Ahidjo BA, Bishai WR (2016) Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis. EBioMedicine 4:7\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2016.02.016","journal-title":"EBioMedicine"},{"key":"2277_CR92","doi-asserted-by":"publisher","first-page":"e80669","DOI":"10.1371\/journal.pone.0080669","volume":"8","author":"A Obreg\u00f3n-Henao","year":"2013","unstructured":"Obreg\u00f3n-Henao A, Henao-Tamayo M, Orme IM, Ordway DJ (2013) Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection. PLoS One 8:e80669. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0080669","journal-title":"PLoS One"},{"key":"2277_CR93","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","volume":"208","author":"C Vilaplana","year":"2013","unstructured":"Vilaplana C, Marzo E, Tapia G et al (2013) Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J Infect Dis 208:199\u2013202. \n                    https:\/\/doi.org\/10.1093\/infdis\/jit152","journal-title":"J Infect Dis"},{"key":"2277_CR94","doi-asserted-by":"publisher","first-page":"e0156549","DOI":"10.1371\/journal.pone.0156549","volume":"11","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wu K, Liu Y et al (2016) Finasteride Enhances the generation of human myeloid-derived suppressor cells by up-regulating the COX2\/PGE2 pathway. PLoS One 11:e0156549. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0156549","journal-title":"PLoS One"},{"key":"2277_CR95","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/cei.12143","volume":"174","author":"N Rieber","year":"2013","unstructured":"Rieber N, Gille C, K\u00f6stlin N et al (2013) Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin Exp Immunol 174:45\u201352. \n                    https:\/\/doi.org\/10.1111\/cei.12143","journal-title":"Clin Exp Immunol"},{"key":"2277_CR96","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/acel.12571","volume":"16","author":"RR Flores","year":"2017","unstructured":"Flores RR, Clauson CL, Cho J et al (2017) Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-\u03baB-dependent mechanism. Aging Cell 16:480\u2013487. \n                    https:\/\/doi.org\/10.1111\/acel.12571","journal-title":"Aging Cell"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-018-2277-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-018-2277-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-018-2277-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T19:08:27Z","timestamp":1576696107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-018-2277-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s00262-018-2277-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}